← Back to headlines
HIV Prevention Drug Faces Access Barriers Despite Global Potential
Experts warn that a promising injectable PrEP drug, capable of significantly reducing new HIV cases globally, faces access challenges due to dramatic worldwide declines in HIV prevention investment, including USAID cuts.
31 Jul, 16:29 — 31 Jul, 16:29
